EquityWhat's this?
Price (GBX)
410.00 1.24% (5.00)
FARNORD NPV (DI)
Track 1 instrument
Open / Last close
- / 405.00
High / Low
410.00 / 400.00
Bid / Offer
390.00 / 430.00
Turnover
-
Special Condition: -
Trading Status: Regular Trading
FTSE AIM All-Share
As at 25.09.20 11:50:29 - All data delayed at least 15 minutes

Faron Pharmaceuticals Oy instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation
FARNORD NPV (DI)410.00
GBX
1.24%Equity-
As at 25.09.20 11:50:29 - All data delayed at least 15 minutes

Price information

What's this?
Open price
-
 Previous close price / date
405.00 / 24 September 2020
 Volume
1,928
 Turnover
-
 52 week range
80.50 / 492.00
 YTD return
47.27
 1 year return
285.71
Display price followed by previous trading day date

Instrument information

What's this?
Market
AIM
 Instrument market cap (£m)
189.54
 Earnings per share
-0.37
 Issue date
17 November 2015
 ISIN
FI4000153309
 SEDOL
BYMKYR0
 Market identifier code (MIC)
AIMX
 Country of share register
GB
 Market segment
ASQ1
 Trading service
SETSqx
 Nominated Advisers
Cairn Financial Advisers LLP
For Bonds - Issue date is for indicative purposes only. For exact dates please refer to bond documentation directly.

Last 5 trades

What's this?
Show me more trades
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
25.09.20 11:33:16 420.00 GBX 152 638.40 Off-Book - AIMX
25.09.20 10:47:54 392.00 GBX 258 1,011.36 Off-Book - AIMX
25.09.20 10:13:24 420.00 GBX 350 1,470.00 Off-Book - AIMX
25.09.20 09:43:01 420.00 GBX 100 420.00 Off-Book - AIMX
25.09.20 09:32:07 420.00 GBX 68 285.60 Off-Book - AIMX
As at 25.09.20 11:50:29 - All data delayed at least 15 minutes
For instruments denominated in GBX, the Trade Value is in GBP when the traded currency is GBX or GBP. When the traded price is any other currency then the Trade Value is displayed in that currency. Some trades qualify for deferred publication due to the type or size of the transaction. These will be displayed at the point of publication, but show the date/time of execution as with other trades.

Equity Research

from Faron Pharmaceuticals Oy
SP Angel Healthcare Conditions

Avacta (AVCT.L): Update on Affimer therapeutics development partnership | Faron Pharmaceuticals Oy (FARN.L): Traumakine update

View report
SP Angel Healthcare Conditions

Novacyt S.A. (NCYT.L): Supply contract with UK Department of Health and Social Care | Omega Diagnostics (ODX.L): Group performs CE-marking of Mologic Ltd’s COVID-19 antibody test | RenalytixAI (RENX.L): Utah Commercial Laboratory Facility Achieves ISO 13485 Certification | Faron Pharmaceuti ...

View report
Small Cap Feast

Caribbean Investment Holdings. Incorporated in Belize . CIHL primarily operates financial services businesses through its subsidiaries The Belize Bank Limited and Belize Bank International Limited, both located in Belize and international corporate services through Belize Corporate Services Limited. ...

View report
Small Cap Feast

Calisen Group. Potential Intention to Float. Owner and manager of essential energy infrastructure assets . Consolidated FY Dec 18 revenue £162.1m and operating profit £25.4m. Raising up to £300m in primary plus partial vendor sale. The Global Sustainable Farmland Income Trust will invest in a divers ...

View report
SP Angel Healthcare Conditions

Faron (FARN.L): Data from Phase 1/2 MATINS trial – from yesterday | Arix Bioscience (ARIX.L): Antibiotic portfolio company narrowly misses endpoint in Phase 3 trial – from yesterday

View report
Issuer presentations live and on demand
Watch on Spark Live

Related links

Search for companies and prices
 Learn more
Personal investing hub
 Learn more
Looking to raise finance
 Learn more
Explore this company
 Learn more

This website contains text, data, graphics, photographs, artworks, names, logos, trademarks and information ("Information"). some of which is connected with London Stock Exchange plc("LSE")(the "LSE Information") and some of which is connected with (and has been made available on LSE's platform by the company that this particular webpage is dedicated to (the "company Information"), LSE attempts to ensure the LSE information is accurate, but has not and does not in any way review the Company Information and both sets of information are provided for information purpose only and are provided "AS IS" and on an "AS AVAILABLE" basis and may not be accurate or up to date. Information on this webpage may or may not have been prepared by LSE but is made available without responsibility on the part of LSE. LSE does not guarantee the accuracy, timeliness, completeness, performance or fitness for a particular purpose of the webpage or any of the Information on it. No responsibility is accepted by or on behalf of the LSE for any errors, omissions, or inaccurate Information on this webpage.

No action should be taken or omitted to be taken in reliance upon information on this webpage. We accept no liability for the result of any action taken on the basis of the Information or for any loss from use of this webpage.

London Stock Exchange, the London Stock Exchange coat of arm device are trademarks of London Stock Exchange plc.

View our other sites Select
© 2020 London Stock Exchange. All rights reserved.